Connection

Mark Hamann to Alzheimer Disease

This is a "connection" page, showing publications Mark Hamann has written about Alzheimer Disease.
Connection Strength

0.476
  1. Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease. J Nat Prod. 2007 Sep; 70(9):1397-405.
    View in: PubMed
    Score: 0.205
  2. Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases. J Nat Prod. 2006 Jul; 69(7):1034-40.
    View in: PubMed
    Score: 0.190
  3. Insights and ideas garnered from marine metabolites for development of dual-function acetylcholinesterase and amyloid-? aggregation inhibitors. Mar Drugs. 2014 Apr 04; 12(4):2114-31.
    View in: PubMed
    Score: 0.081
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.